Division 2
United Kingdom
Whenever blood sampling for serological tests is carried out in holdings located in the surveillance zone, the number of blood samples to be taken in these holdings must be in accordance with section F(2), first sentence.
However, the derogation provided for in Article 10(5) and Article 11(4) of Directive 2002/60/EC may only be granted if the competent authority ensures that in each holding in the zone blood samples for serological tests are taken. The minimum number of blood samples to be taken must allow for the detection of 5 % seroprevalence with 95 % confidence in each subunit in the holding.
Notes on Chapter IV
Textual amendments
- F1
Words in Annex Ch. 4 Section A para. 1 substituted (31.12.2020) by The Exotic Disease (Amendment etc.) (EU Exit) Regulations 2018 (S.I. 2018/1410), regs. 1, 8(5); 2020 c. 1, Sch. 5 para. 1(1)